
South Africa Switches to J&J COVID Vaccines After AstraZeneca Halt
South Africa shifts to Johnson & Johnson COVID-19 vaccines after AstraZeneca shows limited efficacy against local variant, prioritizing public health strategy.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
South Africa shifts to Johnson & Johnson COVID-19 vaccines after AstraZeneca shows limited efficacy against local variant, prioritizing public health strategy.